Filing Details
- Accession Number:
- 0001491877-10-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-24 13:00:00
- Reporting Period:
- 2010-05-20
- Filing Date:
- 2010-05-24
- Accepted Time:
- 2010-05-24 20:31:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 72444 | Nabi Biopharmaceuticals | NABI | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222789 | B Peter Davis | Po Box 4 Quechee VT 05059 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-20 | 3,816 | $5.24 | 14,630 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2010-05-20 | 20,000 | $0.00 | 20,000 | $5.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | 2017-05-20 | No | 4 | A | Direct |
Footnotes
- The purchase reported in this form was made upon election of director to receive his entire annual director fee retainer in common stock pursuant to Section 14 of the 2007 Omnibus Equity and Incentive Plan.
- The Stock Option (right to buy) is exercisable in four equal installments on August 20, 2010, November 20, 2010, February 20, 2011, and May 20, 2011.
Billionaire Hedge Funds
